Skip to Main Content

Paper Details

Enfortumab vedotin in the treatment of urothelial cancers and beyond.
Future Oncol
3
2022
Author NameAffiliation
Evan Y YuUniversity of Washington
Evan Y YuFred Hutchinson Cancer Center
  • 1 - 2

Datasets

Release 1.2